GOLDMAN SACHS GROUP INC - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 68 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$14,000
-98.8%
13,046
-98.1%
0.00%
Q2 2019$1,144,000
+120.8%
672,633
+337.4%
0.00%
Q1 2019$518,000
-13.7%
153,776
-25.2%
0.00%
Q4 2018$600,000
-57.4%
205,661
-10.2%
0.00%
Q3 2018$1,410,000
-27.1%
228,926
-12.7%
0.00%
-100.0%
Q2 2018$1,935,000
+75.1%
262,256
+55.7%
0.00%
Q1 2018$1,105,000
-11.7%
168,484
+13.2%
0.00%
Q4 2017$1,252,000
-16.4%
148,860
+14.9%
0.00%
Q3 2017$1,497,000
-7.1%
129,603
-6.1%
0.00%
Q2 2017$1,612,000
+206.5%
138,000
+223.5%
0.00%
Q1 2017$526,000
+34.2%
42,664
+48.1%
0.00%
Q4 2016$392,000
+58.7%
28,801
+131.8%
0.00%
Q3 2016$247,000
-68.8%
12,424
-79.7%
0.00%
Q2 2016$791,000
-85.9%
61,055
-78.0%
0.00%
-100.0%
Q4 2015$5,619,000
+1567.4%
277,220
+1804.4%
0.00%
Q1 2015$337,000
-60.2%
14,557
-60.4%
0.00%
Q4 2014$847,00036,7500.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 15,086$306,0000.84%
Baker Brothers Advisors 4,865,647$98,627,0000.82%
Cormorant Asset Management, LP 300,000$6,081,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 231,515$4,693,0000.69%
QVT Financial LP 340,986$6,912,0000.39%
Graticule Asia Macro Advisors LLC 87,000$1,763,0000.29%
Hatteras Investment Partners, LP 10,410$211,0000.28%
MCDANIEL TERRY & CO 33,836$686,0000.18%
Highlander Capital Management, LLC 6,500$132,0000.12%
EverPoint Asset Management, LLC 265,000$5,372,0000.11%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders